Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Capped antithrombin III dosing is cost effective in the management of asparaginase-associated thrombosis.

Young J, Sawyer J, Jenkins M, O'Brien M, Luchtman-Jones L, Breese EH.

Pediatr Blood Cancer. 2019 Jun;66(6):e27719. doi: 10.1002/pbc.27719. Epub 2019 Mar 22.

PMID:
30900794
2.

Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosis.

Gurunathan A, Boucher AA, Mark M, Prus KM, O'Brien MM, Breese EH, Mizukawa BE, Absalon MJ, Nelson AS, Jordan MB, Grimley MS, Lorsbach RB, Rotz SJ, Mathanda R, Kumar AR.

Pediatr Blood Cancer. 2018 Dec;65(12):e27400. doi: 10.1002/pbc.27400. Epub 2018 Oct 1.

PMID:
30272386
3.

MLL leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing.

Schneidawind C, Jeong J, Schneidawind D, Kim IS, Duque-Afonso J, Wong SHK, Iwasaki M, Breese EH, Zehnder JL, Porteus M, Cleary ML.

Blood Adv. 2018 Apr 24;2(8):832-845. doi: 10.1182/bloodadvances.2017013748.

4.

Viral surveillance using PCR during treatment of AML and ALL.

Dixon SB, Lane A, O'Brien MM, Burns KC, Mangino JL, Breese EH, Absalon MJ, Perentesis JP, Phillips CL.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26752. Epub 2017 Aug 9.

PMID:
28792686
5.

Use of Genome Engineering to Create Patient Specific MLL Translocations in Primary Human Hematopoietic Stem and Progenitor Cells.

Breese EH, Buechele C, Dawson C, Cleary ML, Porteus MH.

PLoS One. 2015 Sep 9;10(9):e0136644. doi: 10.1371/journal.pone.0136644. eCollection 2015.

6.

MLL leukemia induction by genome editing of human CD34+ hematopoietic cells.

Buechele C, Breese EH, Schneidawind D, Lin CH, Jeong J, Duque-Afonso J, Wong SH, Smith KS, Negrin RS, Porteus M, Cleary ML.

Blood. 2015 Oct 1;126(14):1683-94. doi: 10.1182/blood-2015-05-646398. Epub 2015 Aug 26.

7.

Anti-N-methyl-D-aspartate receptor encephalitis: early treatment is beneficial.

Breese EH, Dalmau J, Lennon VA, Apiwattanakul M, Sokol DK.

Pediatr Neurol. 2010 Mar;42(3):213-4. doi: 10.1016/j.pediatrneurol.2009.10.003.

PMID:
20159432
8.

Tumor necrosis factor alpha induction of NF-kappaB requires the novel coactivator SIMPL.

Kwon HJ, Breese EH, Vig-Varga E, Luo Y, Lee Y, Goebl MG, Harrington MA.

Mol Cell Biol. 2004 Nov;24(21):9317-26.

Supplemental Content

Loading ...
Support Center